These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 11801771

  • 1. P53 protein expression in eccrine poroma and porocarcinoma.
    Akalin T, Sen S, Yücetürk A, Kandiloğlu G.
    Am J Dermatopathol; 2001 Oct; 23(5):402-6. PubMed ID: 11801771
    [Abstract] [Full Text] [Related]

  • 2. p53 protein and proliferating cell nuclear antigen in eccrine poroma and porocarcinoma. an immunohistochemical study.
    Tateyama H, Eimoto T, Tada T, Inagaki H, Nakamura T, Yamauchi R.
    Am J Dermatopathol; 1995 Oct; 17(5):457-64. PubMed ID: 8599450
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemistry of eccrine poroma and porocarcinoma--more than acrosyringeal tumors?
    Wollina U, Castelli E, Rülke D.
    Recent Results Cancer Res; 1995 Oct; 139():303-16. PubMed ID: 7541147
    [Abstract] [Full Text] [Related]

  • 4. Aberrant expression of p16 and RB protein in eccrine porocarcinoma.
    Gu LH, Ichiki Y, Kitajima Y.
    J Cutan Pathol; 2002 Sep; 29(8):473-9. PubMed ID: 12207741
    [Abstract] [Full Text] [Related]

  • 5. Clear-cell porocarcinoma in situ: a cytologic variant of porocarcinoma in situ.
    Rutten A, Requena L, Requena C.
    Am J Dermatopathol; 2002 Feb; 24(1):67-71. PubMed ID: 11803286
    [Abstract] [Full Text] [Related]

  • 6. Eccrine porocarcinoma (malignant eccrine poroma).
    Perna C, Cuevas J, Jiménez-Heffernan JA, Hardisson D, Contreras F.
    Am J Surg Pathol; 2002 Feb; 26(2):272-4. PubMed ID: 11812953
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Apocrine poroma of the breast.
    Azma A, Tawfik O, Casparian JM.
    Breast J; 2001 Feb; 7(3):195-8. PubMed ID: 11469936
    [Abstract] [Full Text] [Related]

  • 11. Eccrine porocarcinoma of the upper eyelid.
    Jain R, Prabhakaran VC, Huilgol SC, Gehling N, James CL, Selva D.
    Ophthalmic Plast Reconstr Surg; 2008 Feb; 24(3):221-3. PubMed ID: 18520840
    [Abstract] [Full Text] [Related]

  • 12. Differentiation of eccrine poroma cells to cytokeratin 1- and 10-expressing cells, the intermediate layer cells of eccrine sweat duct, in the tumor cell nests.
    Ban M, Yoneda K, Kitajima Y.
    J Cutan Pathol; 1997 Apr; 24(4):246-8. PubMed ID: 9138117
    [Abstract] [Full Text] [Related]

  • 13. Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomas.
    Bosic M, Kirchner M, Brasanac D, Leichsenring J, Lier A, Volckmar AL, Oliveira C, Buchhalter I, Stögbauer F, Zivkovic-Perisic S, Goeppert B, Schirmacher P, Penzel R, Endris V, Stenzinger A.
    Pathology; 2018 Apr; 50(3):327-332. PubMed ID: 29269125
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma.
    Russell-Goldman E, Hornick JL, Hanna J.
    J Cutan Pathol; 2021 Mar; 48(3):403-410. PubMed ID: 33222286
    [Abstract] [Full Text] [Related]

  • 18. Benign and malignant eccrine poroma--a flow cytometric comparison.
    Hagler J, Trattner A, Nativ O, Hauben DJ, David M.
    Isr J Med Sci; 1996 Dec; 32(12):1151-3. PubMed ID: 9007142
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.